About Dr. Anil Kumar Anand
Dr Anil Kumar Anand has over 31+ years of rich experience to his credit in the field of radiation oncology. He is an alumni of Dayanand Medical College Ludhiana from where he did is MBBS, followed by MD (Radiotherapy and Oncology) from Post Graduate Institute of Medical Education and Research (PGI) Chandigarh. He has done specialised training in radiation therapy at the New York Hospital Medical Centre of Queens. He has also done specialised training in Radiotherapy of Head and Neck Cancers from The Middlesex Hospital Medical School, London. Dr. Anand has joined FMRI, Gurugram from Max hospital, Saket where he wasassociated as Principal Director-Radiation Oncology since 2009. Previously hewas associated with organizations like Rajiv Gandhi Cancer Institute, BatraHospital and Medical Research Center, New Delhi and PGI Chandigarh. Dr Anand has many scientific publications to his credit, the most recent being Stereotactic Body Radiation Therapy (SBRT)in recurrent head and neck cancers. He is a member of Indian Society of Oncology, American Society of RadiationOncology and Association of Radiation Oncologist of India. He is also an Advisor of Scientific Bodies like (ICRO), WHO andother UN organisations. He is a member of Editorial board, Journal of Cancer Research and Therapeutics.
Hospital
Fortis Hospital
, Delhi NCR
Location
No
Special Interest
List Of Treatments
Chemotherapy
Adrenal Cancer Treatment
Anal Cancer Treatment
Aplastic Anemia
Bile Duct Cancer Treatment
Bladder Cancer Treatment
Bone Cancer Treatment
Brain CNS Tumor Treatment - Adults
Brain CNS Tumors Treatment - Children
Breast Cancer-Surgical
Breast Cancer Treatment for Men
Cancer in Children
Carcinoma of Unknown Primary (CUP) Treatment
Castleman Disease Treatment
Cervical Cancer Treatment
Endometrial Cancer Treatment
Esophagus Cancer Treatment
Ewing Family of Tumors Treatment
Eye Cancer Treatment
Gallbladder Cancer Treatment
Carcinoid Tumors Treatment
Gastrointestinal Stromal Tumor GIST Treatment
Gestational Trophoblastic Disease (GTD) Treatment
Hodgkin Disease Treatment
Kaposi Sarcoma Treatment
Kidney Cancer Treatment
Laryngeal and Hypopharyngeal Cancer Treatment
Acute Lymphocytic Leukemia - ALL in Adults
Leukemia - Acute Myeloid AML
Chronic Lymphocytic Leukemia - CLL
Chronic Myeloid Leukemia- CML
Chronic Myelomonocytic Leukemia - CMML
Leukemia in Children
Liver Cancer
Lung Cancer Treatment
Non-Small Cell Lung Cancer (NSCLC) Treatment
Small-cell Carcinoma Treatment
Lung Carcinoid Tumor Treatment
Skin Lymphoma Treatment
Malignant Mesothelioma Treatment
Multiple Myeloma Treatment
Myelodysplastic Syndrome (MDS) Treatment - Preleukemia
Nasal Cavity and Paranasal Sinus Cancer Treatment
Nasopharyngeal Cancer Treatment
Neuroblastoma
Non-Hodgkin Lymphoma (NHL) Treatment
Non-Hodgkin Lymphoma In Children
Oral Cavity and Oropharyngeal Cancer
Osteosarcoma (OS) Treatment
Ovarian Cancer Surgery
Pancreatic Cancer
Penile Cancer Treatment
Prostate Cancer-Surgical
Retinoblastoma (RB) Treatment
Rhabdomyosarcoma (RMS) Treatment
Salivary Gland Cancer
Soft Tissue Sarcoma Treatment
Skin Cancer
Basal Cell and Squamous Cell Carcinoma
Skin Cancer - Melanoma
Small Intestine Cancer Treatment
Stomach Cancer Treatment
Testicular Cancer Treatment
Thymoma and Thymic Carcinoma Treatment
Thyroid Cancer Treatment
Uterine Sarcoma
Vaginal Cancer Treatment
Vulvar Cancer Treatment
Waldenstrom Macroglobulinemia
Wilms Tumor (Nephroblastoma)
Breast Biopsy
Autologous Stem Cell Transplant for Lymphoma
Allogeneic Bone Marrow Transplant
Pediatric Bone Marrow Transplant
Thalassemia Treatment
Oral Cancer - Surgical
Breast Cancer
Leukemia Treatment
Hairy Cell Leukemia - HCL
Fallopian Tube Cancer
Ovarian Germ Cell Tumor
Ovarian Primary Peritoneal Cancer
Medullary Carcinoma
Papillary Thyroid Cancer Treatment
Bone Marrow Cancer
Ovarian Sex Cord Stromal Tumor
Invasive Lobular Carcinoma
